(Q78367035)
Statements
Rituximab as first-line and maintenance therapy for patients with indolent non-hodgkin's lymphoma (English)
John D Hainsworth
Sharlene Litchy
Howard A Burris
Daniel C Scullin
Steven W Corso
Lisa Morrissey
F Anthony Greco
1 October 2002